The GCMAS is pleased to accept abstracts in the areas of:

• Gait Analysis
• Foot and Ankle
• Trunk and Upper Extremity
• Normal Motion
• Pathological Motion
• Balance/Stability/Posture
• Sports and Sports Performance
• Prosthetics/Orthotics/Assistive Devices
• Muscles/FES/EMG
• Orthopaedics
• Rehabilitation
• Quality Service Delivery and Standards
• Novel Biomechanics
• Data and Analysis Methods
• Tutorials

 

Abstract submission will begin on October 1st, 2020 and end on January 8th, 2021 through the OpenConf Peer Review Conference Management System. Click here to submit an abstract.

If you wish to be a reviewer, please contact the conference chair, Tim Niiler, at tim.niiler@gmail.com.

 

Abstracts are limited to two (2) pages and must be formatted as follows: The content of each page must be contained within a 160 mm X 225 mm (6.3" x 8.8") area. Text should be formatted as Times New Roman 12-pt font.

 

Abstract reviews will not be blinded. For each study submitted, please submit a publication copy of your abstract, which includes the title of the paper, the author(s), affiliation(s) and email address of the corresponding author. The name of the presenting author should be underlined. The presenting author listed on the abstract will be required to complete an online disclosure statement for CME/CEU accreditation. The link to this online disclosure will be sent out after abstract acceptance. See Specific Submission Instructions below for additional information.

 

Abstracts describing original research should be comprised of the following sections: Introduction, Clinical Significance, Methods, Results, Discussion, References, Acknowledgements, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size.

 

Abstracts describing methodological advances should be comprised of the following sections: Introduction, Clinical Significance, Methods, Demonstration, Summary, References, Acknowledgements, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size. Abstracts should describe novel methods (i.e. devices or algorithms) that enhance our ability to visualize, measure, or analyze the mechanics, tendons, joints, and/or limb segments. Abstracts from vendors are encouraged, but must not contain advertising.

 

Abstracts describing clinical case studies should be comprised of the following sections: Subject History, Clinical Data, Motion Data, Treatment Decisions and Indications, Outcome (if available) Summary, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size. Abstracts should illustrate the value of motion analysis and/or modeling in the evaluation, understanding, and/or treatment of a movement disorder. Priority will be given to studies that include pre- and post-treatment data.